You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product namebeta Actin peptideSee all beta Actin proteins and peptides ...
  • Protein descriptionSynthetic peptide derived from within residues 1 - 100 of Human beta Actin.(Note: the amino acid sequence is proprietary)This peptide was used as an immunogen for ab8224 - beta Actin antibody [mAbcam 8224] - Loading Control, ab8226 - beta Actin antibody [mAbcam 8226] - Loading Control, ab8227 - beta Actin antibody - Loading Control, ab8229 - beta Actin antibody, ab13822 - beta Actin antibody - Loading Control and ab75186 - beta Actin antibody - Loading Control.
  • Protein length375 amino acids
  • Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • Storage bufferInformation available upon request.
  • Concentration information loading...
  • Research Areas
  • Applications

    Our Abpromise guarantee covers the use of ab13772 in the following tested applications.

    The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

    Application Notes
    Blocking
  • Application notesBL: Use at a concentration of 1 µg/ml. This peptide can be used with studies using ab8227.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Protein info

    • Alternative names
        A26C1AA26C1BACTB
        ACTB_HUMANActin cytoplasmic 1Actxbeta cytoskeletal actinBeta-actinE430023M04RikMGC128179PS1TP5 binding protein 1PS1TP5BP1
      see all
  • FunctionActins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.
  • Involvement in diseaseDefects in ACTB are a cause of dystonia juvenile-onset (DYTJ) [MIM:607371]. DYTJ is a form of dystonia with juvenile onset. Dystonia is defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYTJ patients manifest progressive, generalized, dopa-unresponsive dystonia, developmental malformations and sensory hearing loss.
  • Sequence similaritiesBelongs to the actin family.
  • Post-translational
    modifications
    ISGylated.
  • Cellular localizationCytoplasm > cytoskeleton. Localized in cytoplasmic mRNP granules containing untranslated mRNAs.
  • Target information above from: UniProt accession P60709 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt

    beta Actin peptide images

    • All lanes : Anti-beta Actin antibody - Loading Control (ab8227) at 1/1000 dilution

      Lane 1 : HeLa nuclear lysate
      Lane 2 : HeLa whole cell lysate
      Lane 3 : A431 cell lysate
      Lane 4 : Jurkat cell lysate
      Lane 5 : HEK 293 cell lysate
      Lane 6 : HeLa nuclear lysate with beta Actin peptide (ab13772) at 1 µg/ml
      Lane 7 : HeLa whole cell lysate with beta Actin peptide (ab13772) at 1 µg/ml
      Lane 8 : A431 cell lysate with beta Actin peptide (ab13772) at 1 µg/ml
      Lane 9 : Jurkate cell lysate with beta Actin peptide (ab13772) at 1 µg/ml
      Lane 10 : HEK 293 cell lysate with beta Actin peptide (ab13772) at 1 µg/ml

      Lysates/proteins at 20 µg per lane.

      Secondary
      Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (HRP) (ab6721) at 1/5000 dilution

      Observed band size : 41.7 kDa (why is the actual band size different from the predicted?)


      Exposure time : 5 seconds

    References for beta Actin peptide (ab13772)

    ab13772 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab13772.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"